Search Results - "Sobotková, Marta"
-
1
Registry‐based analysis of Icatibant and C1‐inhibitor use in treatment of laryngeal attacks of hereditary angioedema
Published in Clinical and experimental allergy (01-08-2022)Get full text
Journal Article -
2
Myeloid lineage cells evince distinct steady-state level of certain gene groups in dependence on hereditary angioedema severity
Published in Frontiers in genetics (04-07-2023)“…Hereditary angioedema (HAE) is a rare genetic disorder with variable expressivity even in carriers of the same underlying genetic defect, suggesting other…”
Get full text
Journal Article -
3
Complement deficiencies
Published in Vnitřní lékar̆stvĭ (08-10-2020)“…Complement system plays a crucial role in innate imunity. Complement deficiencies are often associated with severe infections, usually meningoccocal,…”
Get more information
Journal Article -
4
Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper
Published in Allergy (Copenhagen) (01-08-2022)“…Background Anaphylaxis, which is rare, has been reported after COVID‐19 vaccination, but its management is not standardized. Method Members of the European…”
Get full text
Journal Article -
5
Angiotensin-converting enzyme inhibitor-induced angioedema: epidemiology, pathogenesis and management
Published in Vnitřní lékar̆stvĭ (01-10-2018)“…Angiotensin-converting enzyme-induced angioedema occurs in 0.1-0.7 % of recipients. Swelling often affects head and neck and makes it an extremely dangerous…”
Get more information
Journal Article -
6
Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study
Published in Frontiers in immunology (28-02-2022)“…Despite the progress in the understanding how COVID-19 infection may impact immunocompromised patients, the data on inborn errors of immunity (IEI) remain…”
Get full text
Journal Article -
7
Current trends in immunosuppressive treatment
Published in Vnitřní lékar̆stvĭ (2019)“…Immunosuppressive agents represent a class of drugs that inhibits activity of the immune system. They are mostly used in autoimmune diseases and other…”
Get more information
Journal Article -
8
The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective
Published in Časopis lékařů českých (2023)“…Castleman disease (CD) is a heterogeneous group of diseases characterized by lymphadenopathy and systemic inflammatory manifestations. CD can be divided into…”
Get more information
Journal Article -
9
Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort
Published in Journal of clinical immunology (01-11-2023)“…Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare and life-threatening condition characterized by recurrent localized edema. We…”
Get full text
Journal Article -
10
-
11
Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01-02-2020)“…Hereditary angioedema (HAE), an inherited deficiency of functional C1 esterase inhibitor (C1-INH), is characterized by recurrent episodes of disabling and…”
Get full text
Journal Article